NDT Advance Access originally published online on February 18, 2009
Nephrology Dialysis Transplantation 2009 24(6):1705-1708; doi:10.1093/ndt/gfp069
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Klotho in chronic kidney disease—What's new?
Department of Pathology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390-9072, USA
Correspondence and offprint requests to: Makoto Kuro-o; E-mail: Makoto.Kuro-o@UTSouthwestern.edu
Keywords: CKD; FGF23; Klotho; phosphate; vitamin D
| The first 150 words of the full text of this article appear below. |
| Introduction: Klotho and FGF23 |
|---|
Klotho, named after a Greek goddess who spins the thread of life, was identified in 1997 as a gene mutated in a mouse strain that developed a premature ageing syndrome [1]. A defect in Klotho gene expression in mice results in shortened life span, growth retardation, hypogonadism, accelerated thymic involution, skin atrophy, muscle atrophy, vascular calcification, osteopaenia, pulmonary emphysema, cognition impairment [2], hearing loss [3] and motor neuron degeneration [4] among others. These ageing-like phenotypes are associated with elevated serum levels of 1,25-dihydroxyvitamin D3, phosphate and calcium [5]. The Klotho gene encodes a single-pass transmembrane protein that belongs to a family 1 glycosidase [6] and is expressed primarily in renal tubules. Function of the Klotho protein was not clear at that time.
Fibroblast growth factor-23 (FGF23) was cloned based on sequence similarity to the other members of
| Phosphate metabolism |
|---|
| Phosphate toxicity |
|---|
| Klotho and FGF23 in CKD |
|---|